Correlation Between Cytokinetics and Zentalis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Cytokinetics and Zentalis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cytokinetics and Zentalis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cytokinetics and Zentalis Pharmaceuticals Llc, you can compare the effects of market volatilities on Cytokinetics and Zentalis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cytokinetics with a short position of Zentalis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cytokinetics and Zentalis Pharmaceuticals.
Diversification Opportunities for Cytokinetics and Zentalis Pharmaceuticals
0.25 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Cytokinetics and Zentalis is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Cytokinetics and Zentalis Pharmaceuticals Llc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zentalis Pharmaceuticals and Cytokinetics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cytokinetics are associated (or correlated) with Zentalis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zentalis Pharmaceuticals has no effect on the direction of Cytokinetics i.e., Cytokinetics and Zentalis Pharmaceuticals go up and down completely randomly.
Pair Corralation between Cytokinetics and Zentalis Pharmaceuticals
Given the investment horizon of 90 days Cytokinetics is expected to under-perform the Zentalis Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Cytokinetics is 2.34 times less risky than Zentalis Pharmaceuticals. The stock trades about -0.02 of its potential returns per unit of risk. The Zentalis Pharmaceuticals Llc is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 323.00 in Zentalis Pharmaceuticals Llc on September 3, 2024 and sell it today you would earn a total of 38.00 from holding Zentalis Pharmaceuticals Llc or generate 11.76% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cytokinetics vs. Zentalis Pharmaceuticals Llc
Performance |
| Timeline |
| Cytokinetics |
| Zentalis Pharmaceuticals |
Cytokinetics and Zentalis Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cytokinetics and Zentalis Pharmaceuticals
The main advantage of trading using opposite Cytokinetics and Zentalis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cytokinetics position performs unexpectedly, Zentalis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zentalis Pharmaceuticals will offset losses from the drop in Zentalis Pharmaceuticals' long position.| Cytokinetics vs. Edgewise Therapeutics | Cytokinetics vs. Dyne Therapeutics | Cytokinetics vs. Stoke Therapeutics | Cytokinetics vs. Pliant Therapeutics |
| Zentalis Pharmaceuticals vs. Sana Biotechnology | Zentalis Pharmaceuticals vs. Olema Pharmaceuticals | Zentalis Pharmaceuticals vs. Cullinan Oncology LLC | Zentalis Pharmaceuticals vs. Monte Rosa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |